Athira Pharma Appoints Hans Moebius Chief Medical Officer

Xconomy Seattle — 

Hans Moebius has joined Athira Pharma as chief medical officer. Moebius’s experience includes positions at Ciba-Geigy, Novartis (NYSE: NVS), Merz Pharma, TauRx, and Allergan (NYSE: AGN). Seattle-based Athira, which recently changed its name from M3 Biotechnology, is currently testing lead drug candidate NDX-1017 in a Phase 1 study in patients with Alzheimer’s disease, dementia, or mild cognitive impairment.